Zusammenfassung
Die Strukturformel von BPO findet sich in Abb. 9.1. Die Summenformel lautet C14H10o4. Die Substanz ist wenig löslich in Wasser und Ethanol, löslich in Ether, Aceton und Chloroform. Sie zersetzt sich bei hohen Temperaturen und ist über 6o °C explosiv.
ArtickeFootNote
unter Mitarbeit von J. Fluhr
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Akamatsu H, Komuar J, Miyachi Y, Asada Y, Niwa Y (1990) Suppressive effects of linoleic acid on neutrophil oxygen metabolism and phagocytosis. J Invest Dermatol 95: 271–274
Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y (1991) Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 283: 162–166
Angius AG, Barbareschi M, Cattaneo M, Monti M, Caputo R (1990) Evaluation of the anticomedo effect of azelaic acid using the technique of horny layer biopsy and scanning electron microscopy. G Ital Dermatol Venereol 125: 33-36
Balina LM, Graupe K (1991) The treatment of melasma 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30: 893–895
Bandmann HJ, Agathos M (1985) Die posttherapeutische Benzoylperoxidkontaktallergie bei Ulcus cruris-Patienten. Hautarzt 35: 670–674
Binder RL, Aardema MJ, Thompson ED (1959) Benzoyl peroxide: review of experimental carcinogenesis and human safety data. Prog Clin Biol Res 391: 245–294
Bladon PT, Burke BM, Cunliffe WJ, Forster RA, Holland KT, King K (1986) Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline. Br J Dermatol 114: 493–499
Bojar RA, Holland KT, Cunliffe WJ (1991) The in vitro antimicrobial effects of azelaic acid upon propionibacterium acnes strain P 37. J Antimicrob Chemother 28: 843–853
Bojar RA, Cunliffe AG, Graupe K, Cunliffe WJ, Holland KT (1993) Follicular concentrations of azelaic acid after a single topical application. Br J Dermatol 129: 399–402
Bojar RA, Cunliffe WJ, Holland KT (1995) The short term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermato 1132: 204–208
Brasch J, Friege B (1994) Dicarboxylic acids affect the growth of dermatophytes in vitro. Acta Derm Venereol (Stockh) 74: 347–352
Breathnach AS (1996) Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid and other therapies. Cutis 57: 36–45
Breathnach AS, Robins EJ, Nazzoro-Porro M, Passi S, Picardo M (1989) Hyperpigmentary disorders - mechanism of action. Effect of azelaic acid on melanoma and other tumoral cells in culture. Acta Derm Venereol (Stockh) Suppl 143: 62–66
Budunova IV, Carbajal St, Slaga Th (1998) Effect of diverse tumor promoters on the expressions of gap junctional proteins connexin (Cx) 26, Cx31.1 and Cx 43 in Sencar mouse epidermis. Mol Carcinog 15: 202–214
Burke B, Eady EA, Cunliffe WI (1983) Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol 108: 199–204
Cavicchini S, Caputo R (1989) Long term treatment of acne with 20% azelaic acid cream. Acta Derm Venereol (Stockh) 143: 40-44
Chalker DK, Sharlia A, Smith LG, Swann RW (1983) A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 9: 933–936
Cunliffe WJ, Holland KT (1989) Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne. Acta Derm Venereol (Stockh) Suppl 143: 31–34
De Villez RL (1992) Clinical comparison of the safety and efficacy of Brevoxyl Gel and Benzomycin Gel. Drug Invest 4: 300–304
Detmar M, Mayer-Da-Silva A, Stadler R, Orfanos CE (1989) Effects of azelaic acid on prolifera-tion and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 93: 70–74
Downing DT, Stewart ME, Wertz PW, Strauss JS (1986) Essential fatty acids and acne. J Am Acad Dermatol 14: 221–225
Duteil L, Ortonne JP (1992) Colorimetric assessment of the effects of azelaic acid on light induced skin pigmentation. Photodermatol Photoimmunol Photomed 9: 67–71
Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ (1994) Effects of benzoyl peroxide and erythromycine alone and in combination against antibiotic sensitive and resistant skin bacteria from acne patients. Br J Dermatol 131: 331-336
Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ (1996) The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistent propionibacteria. Br J Dermatol 134: 107–113
Embil K, Nacht S (1996) The microsponge delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. Microencapsulation 13: 575–588
Epstein SS, Arnold E, Andrea J, Bass W, Bishop Y (1972) Detection of chemical mutagens by the dominant lethal assay in the mouse. Toxicol Appl Pharmacol 23: 288–325
Fanta D (1978) Klinische and experimentelle Untersuchungen über die Wirkung von Benzoylperoxid in der Behandlung der Akne. Hautarzt 29: 481–486
Fluhr JW, Barsom O, Gehring W, Gloor M (1999) Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. Vehicle controlled, comparative study in patients with papulopustular acne. Dermatology 198: 273–279
Gassmüller H, Graupe K, Orfanos CE (1985) Azelaic acid and sebum excretion rate. Br J Dermatol 113: 800–802
Gehring W, Bopp R, Rippke F, Gloor M (1999) Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicles. Arzneimittelforschung 49: 634–642
Gianotti B (1989) National and international clinical experiences with azelaic acid cream in the treatment of comedo acne. G Ital Dermatol Venereol 124: 471–477
Gloor M (1990) Benzoylperoxid in der dermatologischen Lokaltherapie. Zentralbl Hautkr 157: 1010–1015
Gloor M, Hummel A, Friederich HC (1975) Experimentelle Untersuchungen zur Benzoylperoxidtherapie der Acne vulgaris. Z Hautkr 50: 657–663
Gloor M, Klump H, Wirth H (1980) Cytokinetic studies on the sebosuppressive effect of drugs using the example of benzoyl peroxide. Arch Derm Res 167: 97–99
Gloor M, Pfahler E, Neumann W, Höffler U, Hoffmann M, Schmid U (1982) Lokale Aknetherapie mit Erythromycin and Benzoylperoxid. Z Hautkr 57: 867–878
Gollnick H, Schramm M (1998) Topical drug treatment in acne. Dermatology 196: 119–125
Graupe K, Cunliffe WJ, Gollnick HP, Zaumseil RP (1996) Efficacy and safety of topical azelaic acid (2o percent cream): an overview of results from european clinical trials and experimental reports. Cutis 57 Suppl 1: 20–35
Hazlewood C, Davies MJ (1996) Benzoyl peroxide-induced damage to DNA and its components: direct evidence for the generation of base adducts, sugar radicals and strand breaks. Arch Biochem Biophys 332: 79–91
Hogan DJ, Wilson ER, Miller AB, Robson D, Holfeld K, Lane P (1991) A study of acne treatments as risk factors for skin cancer of the head and neck. Br J Dermatol 125: 343–348
Holland KT, Roberts CD, Cunliffe WJ, Williams M (1974) A technique for sampling microorgan-isms from pilo-sebaceous ducts. J Appl Bacteriol 37: 289–296
Holland KT, Bojar RA, Cunliffe WJ (1989) The interaction of azelaic acid with propionibacterium acnes. J Invest Dermatol 92: 446
Holzmann H, Morsches R, Benes P (1979) The absorption of benzoyl peroxide from leg ulcers. Arzneimittelforschung 29: 1180–1183
Iversen L, Fogh K, Bojesen G, Kragballe K (1991) Linoleic acid and dihomogammalinoleic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds. Agents Actions 33: 286–291
Jensen 0, Petersen SH, Vesterager L (1980) Contact sensitization to benzoyl peroxide following topical treatment of chronic leg ulcers. Contact Dermatitis 6: 179–182
Kakita LS, Lowe NJ (1998) Azelaic acid and glycolic acid combination therapy for facial hyper-pigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther 20: 960–970
Katsambas A, Graupe K, Stratigos J (1989) Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol (Stockh) Suppl 143: 35–39
Kietzmann M, Löscher W, Arens D, Maaß P, Lubach D (1993) The isolated perfused bovine udder as an in vitro model of percutaneous drug adsorption - skin viability and percutaneous absorption of dexamethasone, benzoyl peroxide and efonemate. J Pharmacol Toxicol Methods 30:75–84
King JK, Egner PA, Kensler TW (1996) Generation of DNA base modification following treat-ment of cultured murine keratinocytes with benzoyl peroxide. Carcinogenesis 17: 317–320
Kligman AM (1995) Acne vulgaris: tricks and treatments. Part I. Cutis 56: 141–143
Korhonen A, Hemminki K, Veinio H (1984) Embryotoxic effects of eight organic peroxides and hydrogen peroxide on three-day chicken embryos. Environ Res 33: 54–61
Kraus AL, Munro IC, Orr JC, Binder RL, Le Boeuf RA, Williams GM (1995) Benzoyl peroxide: an integrated human safety assessment for carcinogenicity. Regul Toxicol Pharmacol 21:87–107
Lauer AC, Ramachandram C, Lieb LM, Niemiec S, Weiner ND (1996) Targeted delivery to the pilosebaceous unit via liposomes. Adv Drug Deliv Rev 18: 311–324
Li L, Margolis LB, Lishko VK, Hoffmann RM (1992) Product-delivering liposomes specifically target hair follicles in histocultured intact skin. In Vitro Cell Dev Bio: 28A: 679–681
Lieb LM, Ramachandran C, Egbaria K, Weiner N (1992) Topical delivery enhancement with multilamellar liposomes via the pilosebaceous route: I. In vitro evaluation using fluorescent techniques with the hamster ear model. J Invest Dermatol 99: 108–113
Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers StE, Huerter ChJ, Swinehart JM, Schelling D J, Klauda HC (1997) Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double blind investigations. J Am Acad Dermatol 37: 590–595
Lowe NJ, Rizk D, Grimes D, Billips M, Pincus S (1998) Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 20: 945–959
Maddin S (1999) A comparison of topical acelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 40: 961–965
Maple PA, Hamilton-Miller JA, Brumfitt W (1992) Comparison of the in vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sufphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 28: 843–853
Mayer-Da-Silva A, Gollnick H, Detmar M, Gassmüller J, Parry A, Müller R, Orfanos CE (1989) Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin - an in vivo and in vitro study. Acta Derm Venereol (Stockh) Suppl 143: 20–30
McLean DI, Peter KK (1986) Apparent progression of lentigo maligna to invasive melanoma during treatment with topical azelaic acid. Br J Dermatol 114: 685–689
Merk HF, Bickers DR (1992) Dermatopharmakologie and Dermatotherapie. Blackwell Wissenschaft, Berlin S 919–522
Mezick J A, Thorne E G, Bhatia M C, Shea L M, Capetola J R (1987) The rabbit ear microcomedo prevention assay. A new model to evaluate antiacne agents In: Maibach HI, Lowe NJ (eds) Models in dermatology, vol 3. Karger, Basel München Paris London New York New Delhi Singapore Tokyo Sydney, pp 68–73
Miller CC, Ziboh VA (1990) Inducation of epidermal hyperproliferation by topical n-3 polyunsaturated fatty acids on guinea pig skin linked to decreased levels of 15-hydroxyoctadecadienoic acid (15-HETE). J Invest Dermatol 94: 353–358
Monographie Benzoylperoxid (1990). Pharm Z 135: 1841
Nacht S, Yeung D, Beasley JN, Anjo MA, Maibach HI (1981) Benzoylperoxide: percutaneous penetration and metabolic disposition. J Am Acad Dermatol 4: 31–37
Nazzaro-Porro M (1987) Azelaic acid. J Am Acad Dermatol 17: 1033–1041
Nazzaro-Porro M, Passi S, Picardo M, Breathnach A, Clayton R, Zina G (1983) Beneficial effect of 15% azelaic acid cream on acne vulgaris. Br J Dermatol 109: 45–48
Nazzaro-Porro M, Passi S, Zina G, Breathnach A, Clayton R (1989) Ten years experience of treating lentigo maligna with topical azelaic acid. Acta Derm Venereol (Stockh) Suppl 143: 49–57
Niemiec S, Ramachandran C, Weiner N (1995) Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: An in vivo study using the hamster ear model. Pharm Res 12: 1184–1188
Nüssgen AI, Fritz U, Graupe K, Breitbart EW, Schmiegelow P (1989) Topographical analysis of proliferation ((3H)thymidine labelling index and mitotic index) as compared with tumor growth and tumour weight in xenotransplanted melanoma-changes due to local and systemic application of azelaic acid. Acta Derm Venereol (Stockh) Suppl 143: 67–74
Oh Ch W, Myung KB (1996) An ultrastructural study of the retention hyperkeratosis of experimentally induced comedones in rabbits: the effects of three comedolytics. J Dermatol 23: 169–180
Packmann A M (1996) Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol 35: 209–211
Passi S, Nazzaro-Porro M, Picardo M, Mingrone G, Fasella P (1983) Metabolism of straight sa-turated medium chain length (C 9 - C 12) dicarboxylic acids. J Lipid Res 34: 1140–1147
Passi S, Picardo M, Mingrone G, Breathnach AS, Nazzaro-Porro M (1989) Azelaic acid-biochem-istry and metabolism. Acta Derm Venereol (Stockh) Suppl 143: 8–13
Pattarino F (1994) Topical delivery systems for azelaic acid: effect of the suspended drug in microemulsion. Pharmazie 49: 72–73
Perisho K, Wertz PW, Madison KC, Stewart ME, Downing D T (1988) Fatty acids acylceramides from comedones and from the skin surface of acne patients and control subjects. J Invest Dermatol 90: 350–353
Piérard GE, Piérard-Franchimont C, Goffin V (1995) Digital image analysis of microcomedones. Dermatology 190: 99–103
Puschmann M (1982) Klinisch-experimentelle Untersuchungen zum Wirkungsnachweis von Benzoylperoxid. Hautarzt 33: 257–265
Shalita AR, Smith EB, Bauer E (1984) Topical erythromycin vs. clinidamycin therapy for acne: a multicenter, double-blind comparison. Arch Dermatol 120: 351–355
Slaga TJ, Klein-Szanto AJP, Triplett LL, Yotti LP (1981) Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating component. Science 213: 1023–1025
Stewart ME, Grahak MO, Gambier LS (1986a) Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal alcylceramides. J Invest Dermatol 87: 733–736
Stewart ME, Greenwood R, Cunliffe WJ, Strauss JS (1986b) Effect of cyproterone acetate-ethinyl estradiol treatment on the proportions of linoleic and sebaleic acids in various skin surface lipid classes. Arch Dermatol Res 278: 481-485
Strauss JS, Stewart ME, Downing DT (1987) The effect of 13-cis-retinoic acid on sebaceous glands. Arch Dermatol 123: 1538–1541
Swinyer LJ, Baker MD, Swinyer TA, Mills OH Jr (1988) A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris. Br J Dermatol 119: 615–622
Täuber U, Weiß G, Matthes H (1992) Percutaneous absorption of azelaic acid in humans. Exp Dermatol 1: 176–179
Töpert M, Rach P, Siegmund F (1989) Pharmacology and toxicology of azelaic acid. Acta Derm Venereol (Stockh) Suppl 143: 14–19
Toyoda M, Morohashi M (1998) An overview of topical antibiotics for acne treatment. Dermatology 196: 130–134
Tucker SB, Tausend R, Cochran R, Flannigan SA (1984) Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol no: 487–492
Tucker S, Flannigan S, Dunbar M (1986) Development of an objective comedogenicity assay. Arch Dermatol 122: 660–665
Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L, Garcia-Lopez M (1989) Double blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol (Stockh) Suppl 143: 59–61
Webster GF (1998) Inflammatory acne represents hypersensivity to propionibacterium acnes. Dermatology 196: 80–81
Weinberg JM, Moss T, Gupta SM, White SM, Dohn PhC (1998) Reticulate hyperpigmentation of the skin after topical application of benzoyl-peroxide. Acta Derm Venereol (Stockh) 78: 302–303
Wertz PW, Miethke MC, Long SA, Strauss JS, Downing DT (1985) The composition of the ceramides from human stratum corneum and from comedones. J Invest Dermatol 84: 410–412
Wester RC, Patel S, Nacht S, Leyden J, Melendres J, Maibach H (1991) Controlled release of benzoyl peroxide from a porous microspheric system can reduce topical irritancy. J Am Acad Dermatol 24: 720–726
Wirth H, Spürgel D, Gloor M (1983) Untersuchungen zur Wirkung von Benzoylperoxid auf die Talgdrüsensekretion. Dermatol Monatsschr 169: 289–293
Yeung D, Nacht S, Buchs D, Maibach HI (1983) Benzoyl peroxide: percutaneous penetration and metaboilic circulation, II. Effect of concentration. J Am Acad Dermatol 6: 920–924
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gloor, M. (2000). Benzoylperoxid (BPO) und Azelainsäure (AZ). In: Dermatologische Externatherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58308-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-58308-7_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63533-5
Online ISBN: 978-3-642-58308-7
eBook Packages: Springer Book Archive